Site notifications

Sub menu

 
 

Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2018 - Jun 2019

Last updated

The documents released under Section 11C of the Freedom of Information Act 1982 have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Contact Officer by emailing or calling the Department of Health on 1800 020 103 or 02 6289 1555.

Date of release FOI number Documents
19 June 2019 FOI 1097-1819

A document relating to the registration and adverse events for spinal cord stimulators
11 June 2019 FOI 1154-1819

Documents relating to authorised prescribers for Restasis and other cyclosporine eye drops
5 June 2019 FOI 1088-1819

Advisory Committee on Complementary Medicines (ACCM) meeting minutes from 2018

Irrelevant information removed under section 22
22 May 2019 FOI 1002-1819

All adverse reaction reports relating to all HPV vaccines that are not available on the Database of Adverse Events Notification (DAEN)
15 May 2019 FOI 959-1819

S22(1): Documents containing information that is irrelevant to FOI request

Section 47(1)(b): Document is exempt as it contains a trade secret or information that has commercial value that could reasonably be expected to be destroyed or diminished if it were disclosed
13 May 2019 FOI 1032-1819

Correspondence concerning the scheduling of alkyl nitrites
24 April 2019 FOI 1020-1819

Documents relating to M-COR hip replacement devices between 2006 and 2018 including recall notices, hazard alerts, and adverse event notices
23 April 2019 FOI 1095-1819

Number of applications/ notifications to access Restasis through the Special Access Scheme
17 April 2019 FOI 1042-1819

Product Information document for Stamaril prior to November 2006

Historical documents only - please refer to the current Product Information document for Stamaril.
10 April 2019 FOI 1081-1819

SAS Category B medicinal cannabis applications for the period 1/11/2016 to 15/03/2019
19 February 2019 FOI 946-1819

Inclusion of any drug bioequivalent to Spiriva on the Australian Register of Therapeutic Goods
4 February 2019 FOI 925-1819

Unapproved medicinal cannabis products
1 February 2019 FOI 991-1819

Medicinal Cannabis Category B approvals in Australia for the period May 2018 to December 2018 (inclusive), including indication
23 January 2019 FOI 955-1819

Common Technical Documents for Duloxetine
17 January 2019 FOI 967-1819

SAS B approvals for medicinal cannabis
6 December 2018 FOI 886-1819

Request for documents relating to the advertising of vaccination services and/or vaccines.
28 November 2018 FOI 841-1819

Rescheduling of Alkyl Nitrites
5 November 2018 FOI 846-1819

SAS Trientine Dihydrochloride
6 August 2018 FOI 215-1718

Post market surveillance data & adverse events for traditional Chinese/homeopathic medicines
22 June and 25 July 2018 FOI 229-1718

SMR L2 Back Glenoid Component
20 July 2018 FOI 139-1718

Deaths by suicide in paroxetine clinical trials
1 Jul 2017 to 30 Jun 2018 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018
1 Jul 2016 to 30 Jun 2017 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017
1 Jul 2015 to 30 Jun 2016 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016
1 Jul 2014 to 30 Jun 2015 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015
1 Jul 2013 to 30 Jun 2014 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014
1 Jul 2012 to 30 Jun 2013 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013
1 Jul 2011 to 30 Jun 2012 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Topics

Help us improve the Therapeutic Goods Administration site